| scholarly article | Q13442814 |
| P50 | author | Jian-Min Feng | Q91969527 |
| P2093 | author name string | Yi Wang | |
| Chuan He | |||
| Zhi-Hong Liu | |||
| Hong-Yi Wang | |||
| Kai-di Zhou | |||
| P2860 | cites work | The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis | Q80206688 |
| Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial | Q86971827 | ||
| Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty | Q87445238 | ||
| Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty | Q87654595 | ||
| Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study | Q87758762 | ||
| Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty | Q87846916 | ||
| Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty | Q93937185 | ||
| Tranexamic acid: a review of its use in surgery and other indications | Q33684291 | ||
| Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009. | Q34159025 | ||
| Clinical pharmacology of aminocaproic and tranexamic acids | Q34302597 | ||
| Systemic hemostatic medications for reducing surgical blood loss | Q34325848 | ||
| Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases | Q36327509 | ||
| Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? | Q36634947 | ||
| Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty | Q37253804 | ||
| Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials | Q37325204 | ||
| A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. | Q38236234 | ||
| The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases | Q38512062 | ||
| The response of the fibrinolytic system in trauma. | Q39823641 | ||
| Seroprevalence of hepatitis viruses and risk factors in blood donors of Veracruz, Mexico. | Q41222440 | ||
| Prediction of blood volume in normal human adults. | Q41564951 | ||
| Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial | Q41730481 | ||
| A systematic review and meta-analysis comparing combined intravenous and topical tranexamic acid with intravenous administration alone in THA | Q42706668 | ||
| Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. | Q42837549 | ||
| Use of Intravenous Tranexamic Acid to Reduce Allogeneic Blood Transfusion in Total Hip and Knee Arthroplasty: A Meta-analysis | Q44644645 | ||
| The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty | Q44986260 | ||
| Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial | Q45737273 | ||
| Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). | Q46468416 | ||
| Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration. | Q50797250 | ||
| Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. | Q53308290 | ||
| Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. | Q53576241 | ||
| Estimating allowable blood loss: corrected for dilution | Q71676684 | ||
| Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis | Q72815075 | ||
| The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty | Q73127997 | ||
| Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty | Q73446457 | ||
| How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account | Q74115135 | ||
| An analysis of blood management in patients having a total hip or knee arthroplasty | Q78108769 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tranexamic acid | Q418666 |
| P304 | page(s) | e0204551 | |
| P577 | publication date | 2018-10-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Is topical or intravenous tranexamic acid preferred in total hip arthroplasty? A randomized, controlled, noninferiority clinical trial | |
| P478 | volume | 13 |
Search more.